World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
58
Citations
13890
World Ranking
13066
National Ranking
930

Overview

Holger Hebart is affiliated with the University of Tübingen in Germany. Their research primarily spans the field of Medicine, with a focus on several specialized subfields such as Genetics, Oncology, Pathology and Forensic Medicine, Hematology, and Pulmonary and Respiratory Medicine.

The scientist's work addresses a range of topics, notably:

  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Advanced Breast Cancer Therapies
  • Chronic Myeloid Leukemia Treatments
  • Immunodeficiency and Autoimmune Disorders
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • COVID-19 and healthcare impacts

Holger Hebart has contributed to several publications appearing in prominent scientific journals. Frequent publication venues include:

  • Blood
  • HemaSphere
  • Hematological Oncology
  • International Journal of Cancer
  • Journal of Allergy and Clinical Immunology

Selected recent papers authored or co-authored by Holger Hebart include:

  • First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia, 2023, New England Journal of Medicine
  • Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study, 2023, The Lancet
  • Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany, 2020, Haematologica
  • High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations, 2023, Blood
  • A Randomized Phase III Study of Venetoclax-Based Time-Limited Combination Treatments (RVe, GVe, GIVe) Vs Standard Chemoimmunotherapy (CIT: FCR/BR) in Frontline Chronic Lymphocytic Leukemia (CLL) of Fit Patients: First Co-Primary Endpoint Analysis of the International Intergroup GAIA (CLL13) Trial, 2021, Blood

Holger Hebart frequently collaborates with several co-authors, including:

  • Stephan Stilgenbauer
  • Barbara Eichhorst
  • Kirsten Fischer
  • Eugen Tausch
  • Michael Hallek

Best Publications

  • Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy.

    Hermann Einsele;Eddy Roosnek;Nathalie Rufer;Christian Sinzger

  • Detection and identification of fungal pathogens in blood by using molecular probes.

    H. Einsele;H. Hebart;G. Roller;J. Löffler

  • Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation

    Einsele H;Ehninger G;Hebart H;Wittkowski Km

  • Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol Δ5,6-desaturation

    S.L Kelly;D.C Lamb;D.E Kelly;N.J Manning

  • Quantification of Fungal DNA by Using Fluorescence Resonance Energy Transfer and the Light Cycler System

    Juergen Loeffler;Norbert Henke;Holger Hebart;Diethard Schmidt

  • Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies

    Holger Hebart;Claudia Bollinger;Paul Fisch;Jacqueline Sarfati

  • Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

    Rüdiger Hehlmann;Michael Lauseker;Susanne Saußele;Markus Pfirrmann

  • Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome.

    C. Sinzger;K. Schmidt;J. Knapp;M. Kahl

  • Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection.

    H Einsele;H Hebart;C Kauffmann-Schneider;C Sinzger

  • Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

    Sabine Mousset;Dieter Buchheidt;Werner Heinz;Markus Ruhnke

  • Early Detection of Aspergillus Infection after Allogeneic Stem Cell Transplantation by Polymerase Chain Reaction Screening

    Holger Hebart;Jürgen Löffler;Christof Meisner;François Serey

  • Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus.

    S. Riegler;H. Hebart;H. Einsele;P. Brossart

  • Aspergillus fumigatus antigens activate innate immune cells via toll-like receptors 2 and 4.

    Sibylla Braedel;Markus Radsak;Hermann Einsele;Jean-Paul Latgé

  • Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease

    H Krause;H Hebart;G Jahn;C A Müller

  • Sensitive detection of human cytomegalovirus peptide–specific cytotoxic T-lymphocyte responses by interferon-γ–enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation

    Holger Hebart;Senay Daginik;Stefan Stevanovic;Ulrich Grigoleit

  • Contaminations Occurring in Fungal PCR Assays

    Juergen Loeffler;Holger Hebart;Ralf Bialek;Lars Hagmeyer

  • Comparison of different methods for extraction of DNA of fungal pathogens from cultures and blood.

    J Löffler;H Hebart;U Schumacher;H Reitze

  • Molecular analysis of cyp51 from fluconazole-resistant Candida albicans strains

    Jürgen Löffler;Steven L Kelly;Holger Hebart;Ulrike Schumacher

  • Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML Study IV

    Susanne Saußele;Marie-Paloma Krauß;Rüdiger Hehlmann;Michael Lauseker

  • Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia.

    Holger Hebart;Jürgen Löffler;Heike Reitze;Andreas Engel

Frequent Co-Authors

Hermann Einsele
Hermann Einsele University of Würzburg
Lothar Kanz
Lothar Kanz University of Tübingen
Gerhard Jahn
Gerhard Jahn University of Tübingen
Hartmut Döhner
Hartmut Döhner University of Ulm
Michael Hallek
Michael Hallek University of Cologne
Andreas Reiter
Andreas Reiter Heidelberg University
Andreas Hochhaus
Andreas Hochhaus Friedrich Schiller University Jena
Konstanze Döhner
Konstanze Döhner University of Ulm
Ernst Holler
Ernst Holler University of Regensburg
Jay S. Loeffler
Jay S. Loeffler Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry opens the door to a range of online degrees and diverse careers—including opportunities at the intersection of healthcare and technology. Graduates may find rewarding roles in the fast-growing field of medical coding, where knowledge of biological sciences is a strong asset.

It’s important to understand the differences in certification options, such as ccs vs cpc certification. Each pathway has unique requirements, costs, and benefits that affect career potential. For those considering this route, learning how much does a medical coder make can help in making an informed decision.

The medical coding job outlook is promising, with widespread demand across healthcare settings. If you’re interested in advancing your credentials, a bachelor's degree health information management program offers a flexible online option geared toward preparing students for leadership roles in health information.

Best Scientists Citing Holger Hebart

Trending Scientists

Recently Published Articles